Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.
Li YW, Dai LJ, Wu XR, Zhao S, Xu YZ, Jin X, Xiao Y, Wang Y, Lin CJ, Zhou YF, Fu T, Yang WT, Li M, Lv H, Chen S, Grigoriadis A, Jiang YZ, Ma D, Shao ZM.
Li YW, et al. Among authors: wang y.
Cancer Res. 2024 Nov 4;84(21):3669-3683. doi: 10.1158/0008-5472.CAN-23-4066.
Cancer Res. 2024.
PMID: 39186675